HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanitizer Popularity Obliges FDA Alert To Avoid Clarcon Products

This article was originally published in The Rose Sheet

Executive Summary

FDA says a spike in the use of hand sanitizers influenced its warning not to use any Clarcon Biological Chemistry Laboratory skin sanitizers in a measure that exceeds the agency's routine communication strategy and the firm's recall

You may also be interested in...



FDA's Messages To Public Must Be "News You Can Use" - CHPA

The Consumer Healthcare Products Association urges FDA to make its messages informative and with clear directions when communicating emerging safety issues to the public

FDA's Messages To Public Must Be "News You Can Use" - CHPA

The Consumer Healthcare Products Association urges FDA to make its messages informative and with clear directions when communicating emerging safety issues to the public

FDA Seizes More Than $2.7 Mil. Of Tainted Clarcon Sanitizers, Despite Recall

The U.S. Marshals Service seized more than $2.7 million worth of skin sanitizers and ingredients from Clarcon Biological Chemical Laboratory's Roy, Utah facility July 31, even though the firm voluntarily recalled contaminated products in June

Related Content

UsernamePublicRestriction

Register

RS016223

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel